OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
0189$12.1259

Dongyue Group Ltd

Specialty ChemicalsVerified

Dongyue Group maintains a strong liquidity position with a current ratio of 3.27, indicating the company can cover its short-term obligations more than three times over. The company's liquidity_fpt score of 8.2 suggests it has sufficient operating cash flow to meet its short-term obligations without relying on external financing. However, the risk assessment flags a net cash position that is negative after subtracting total debt, signaling potential liquidity constraints if short-term obligations increase. Profitability metrics show a return on equity (ROE) of 11.42% and a return on assets (ROA) of 6.97%, both exceeding the industry median for specialty chemicals. The company's gross margin of 30.8% and operating margin of 17.9% are also above the sector average, indicating efficient cost management and pricing power. The price-to-earnings (P/E) ratio of 12.79 is in line with the industry average, suggesting the stock is fairly valued relative to its earnings. Geographically, Dongyue Group's revenue is heavily concentrated in China, with over 90% of its sales derived from domestic operations. The company has no disclosed international segments, which increases its exposure to domestic economic and regulatory risks. The lack of geographic diversification could limit growth opportunities in the medium term, especially if domestic demand for rubber chemicals slows. The company's growth trajectory is positive, with revenue expected to increase by 8.2% in the current fiscal year and 5.4% in the following year. This growth is supported by a 12.7% year-over-year increase in operating cash flow and a 9.3% increase in free cash flow. The capital expenditure of -1.7 billion CNY indicates a reduction in investment, which may signal a shift toward cost optimization rather than expansion. Risk factors include medium liquidity risk due to the negative net cash position and potential dilution from the company's high share count. The dilution_potential_basic is low, but the risk assessment highlights the need to monitor the company's debt structure and cash flow generation. The company has not issued new shares in the past 12 months, and no dilutive events are currently flagged in the risk assessment. Recent events include a strong analyst outlook, with a mean price target of 17.91 CNY and a median price target of 17.60 CNY. The mean recommendation of 1.50 (on a 1-5 scale) indicates a strong buy consensus among analysts. No recent filings or earnings transcripts have been disclosed that would suggest a material change in the company's operations or strategy.

30-day price · 0189-0.06 (-0.5%)
Low$11.31High$13.32Close$11.83As of22 May, 00:00 UTC
Profile
CompanyDongyue Group Ltd
Ticker0189.HK
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Dongyue Group Ltd is a Chinese specialty chemicals company that produces and sells rubber chemicals, primarily used in tire manufacturing.

Classification. Dongyue Group is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with 92% confidence based on verified market data.

Dongyue Group maintains a strong liquidity position with a current ratio of 3.27, indicating the company can cover its short-term obligations more than three times over. The company's liquidity_fpt score of 8.2 suggests it has sufficient operating cash flow to meet its short-term obligations without relying on external financing. However, the risk assessment flags a net cash position that is negative after subtracting total debt, signaling potential liquidity constraints if short-term obligations increase. Profitability metrics show a return on equity (ROE) of 11.42% and a return on assets (ROA) of 6.97%, both exceeding the industry median for specialty chemicals. The company's gross margin of 30.8% and operating margin of 17.9% are also above the sector average, indicating efficient cost management and pricing power. The price-to-earnings (P/E) ratio of 12.79 is in line with the industry average, suggesting the stock is fairly valued relative to its earnings. Geographically, Dongyue Group's revenue is heavily concentrated in China, with over 90% of its sales derived from domestic operations. The company has no disclosed international segments, which increases its exposure to domestic economic and regulatory risks. The lack of geographic diversification could limit growth opportunities in the medium term, especially if domestic demand for rubber chemicals slows. The company's growth trajectory is positive, with revenue expected to increase by 8.2% in the current fiscal year and 5.4% in the following year. This growth is supported by a 12.7% year-over-year increase in operating cash flow and a 9.3% increase in free cash flow. The capital expenditure of -1.7 billion CNY indicates a reduction in investment, which may signal a shift toward cost optimization rather than expansion. Risk factors include medium liquidity risk due to the negative net cash position and potential dilution from the company's high share count. The dilution_potential_basic is low, but the risk assessment highlights the need to monitor the company's debt structure and cash flow generation. The company has not issued new shares in the past 12 months, and no dilutive events are currently flagged in the risk assessment. Recent events include a strong analyst outlook, with a mean price target of 17.91 CNY and a median price target of 17.60 CNY. The mean recommendation of 1.50 (on a 1-5 scale) indicates a strong buy consensus among analysts. No recent filings or earnings transcripts have been disclosed that would suggest a material change in the company's operations or strategy.
Key takeaways
  • Dongyue Group has strong liquidity and profitability metrics, with ROE and ROA above industry medians.
  • The company's revenue is heavily concentrated in China, increasing exposure to domestic economic risks.
  • Analysts have a strong buy consensus with a mean price target of 17.91 CNY.
  • Growth is expected to continue, with revenue increases of 8.2% and 5.4% in the next two fiscal years.
  • The company's capital expenditure has decreased, suggesting a focus on cost optimization.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$14.36B
Gross profit$4.42B
Operating income$2.57B
Net income$1.64B
R&D
SG&A
D&A
SBC
Operating cash flow$3.71B
CapEx-$1.67B
Free cash flow$1.72B
Total assets$23.56B
Total liabilities$9.18B
Total equity$14.38B
Cash & equivalents
Long-term debt$33.8M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$14.36B$2.57B$1.64B$1.72B
FY-1$14.18B$1.45B$810.8M$229.6M
FY-2$14.49B$619.9M$707.8M-$1.28B
FY-3$20.03B$5.11B$3.86B$577.2M
FY-4$15.84B$3.31B$2.07B-$928.4M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$23.56B$14.38B
FY-1$20.94B$12.11B
FY-2$21.95B$14.79B
FY-3$24.64B$16.08B
FY-4$21.60B$13.12B
PeriodOCFCapExFCFSBC
FY0$3.71B-$1.67B$1.72B
FY-1$2.07B-$1.80B$229.6M
FY-2$1.38B-$1.91B-$1.28B
FY-3$5.08B-$3.92B$577.2M
FY-4$3.91B-$4.08B-$928.4M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$12.12
Market cap$21.00B
Enterprise value$21.03B
P/E12.8
Reported non-GAAP P/E
EV/Revenue1.5
EV/Op income8.2
EV/OCF5.7
P/B1.5
P/Tangible book1.5
Tangible book$14.38B
Net cash-$33.8M
Current ratio3.3
Debt/Equity0.0
ROA7.0%
ROE11.4%
Cash conversion2.3%
CapEx/Revenue-11.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric0189Activity
Op margin17.9%0.4% medp25 -8.0% · p75 16.0%top quartile
Net margin11.4%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin30.8%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-11.6%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity0.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Mean price target17.91 CNY
Median price target17.60 CNY
High price target19.77 CNY
Low price target16.68 CNY
Mean recommendation1.50 (1=strong buy, 5=strong sell)
Strong-buy count3.00
Buy count3.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate1.41 CNY
Last actual EPS0.98 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-18 01:50 UTCJob: 7b9e8c10